ATC code L

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

ATC code L Antineoplastic and immunomodulating agents is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL.[4]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

L Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L02 Endocrine therapy
L03 Immunostimulants
L04 Immunosuppressants

References[edit]

  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 2020-02-01.
  2. ^ "ATC-Klassifikation mit definierten Tagesdosen DDD" (in German). German Institute for Medical Documentation and Information. Retrieved 2020-02-01.
  3. ^ "ATC/DDD Index 2020: code L". WHO Collaborating Centre for Drug Statistics Methodology.
  4. ^ "ATCvet Index 2020: code QL". WHO Collaborating Centre for Drug Statistics Methodology.